Nano-LC-MS/MS for Quantification of Lyso-Gb3 and Its Analogues Reveals a Useful Biomarker for Fabry Disease

• Hideaki Sueoka,

  Affiliation Genomic Science Laboratories, Sumitomo Dainippon Pharma Co., Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554–0022, Japan

  ⨯
• Junji Ichihara,

  Affiliation Drug Development Research Laboratories, Sumitomo Dainippon Pharma Co., Ltd., 33–94 Enokicho, Suita, Osaka 564–0053, Japan

  ⨯
• Takahiro Tsukimura,

  Affiliation Department of Functional Bioanalysis, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204–8588, Japan

  ⨯
• Tadayasu Togawa,

  Affiliation Department of Functional Bioanalysis, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204–8588, Japan

  ⨯
• Hitoshi Sakuraba

  * E-mail: sakuraba@my-pharm.ac.jp

  Affiliation Department of Clinical Genetics, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204–8588, Japan

  ⨯